Related Experiment Video

Updated: Jun 11, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

NOX2 deficiency protects against streptozotocin-induced beta-cell destruction and development of diabetes in mice

Fu-Li Xiang1, Xiangru Lu, Brenda Strutt

  • 1Department of Medicine, University of Western Ontario, Lawson Health Research Institute, London, Ontario, Canada.

Diabetes
|July 15, 2010
PubMed
Abstract

Insights

NOX2 deficiency protects against diabetes by reducing reactive oxygen species (ROS) and immune responses, preserving pancreatic beta-cell function and mass. This finding offers new insights into diabetes development and potential therapeutic targets.

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • The role of NOX2-containing NADPH oxidase in diabetes pathogenesis is unclear.
  • Reactive oxygen species (ROS) and immune responses are implicated in beta-cell dysfunction.
  • Understanding NOX2's impact is crucial for diabetes research.

Purpose of the Study:

  • To investigate if NOX2 deficiency protects against streptozotocin (STZ)-induced diabetes.
  • To determine if NOX2 deficiency reduces ROS production and immune response.
  • To assess the effect of NOX2 deficiency on beta-cell destruction and function.

Main Methods:

  • Mice models (wild-type, NOX2 knockout) were used with STZ induction.
  • Blood glucose, insulin levels, and glucose tolerance were monitored.
  • Beta-cell apoptosis, mass, ROS production, and immune cell responses were analyzed.

Main Results:

  • NOX2 knockout mice showed improved glucose control and insulin levels post-STZ.
  • Beta-cell apoptosis and insulitis were reduced, while beta-cell mass increased in NOX2 knockout mice.
  • ROS production and pro-inflammatory cytokine release were decreased in NOX2 knockout models.

Conclusions:

  • NOX2 deficiency protects against STZ-induced diabetes.
  • Reduced ROS production and immune response contribute to preserved beta-cell function.
  • NOX2 is a potential therapeutic target for diabetes management.

More Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...